HFS
Haverford Financial Services Portfolio holdings
AUM
$338M
This Quarter Return
+2.92%
1 Year Return
+18.63%
3 Year Return
+58.64%
5 Year Return
+108.28%
10 Year Return
+224.83%
AUM
$237M
AUM Growth
+$237M
(+1.9%)
Cap. Flow
+$750K
Cap. Flow
% of AUM
0.32%
Top 10 Holdings %
Top 10 Hldgs %
45.34%
Holding
62
New
3
Increased
7
Reduced
28
Closed
2
Top Buys
| 1 |
Nike
NKE
|
$4.56M |
| 2 |
Comcast
CMCSA
|
$2.87M |
| 3 |
VSM
Versum Materials, Inc.
VSM
|
$314K |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$230K |
| 5 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
$19.6K |
Top Sells
| 1 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
$5.83M |
| 2 |
GSK
GSK
|
$241K |
| 3 |
Gilead Sciences
GILD
|
$134K |
| 4 |
AB InBev
BUD
|
$91.4K |
| 5 |
Medtronic
MDT
|
$91.4K |
Sector Composition
| 1 | Healthcare | 22.98% |
| 2 | Financials | 18.81% |
| 3 | Consumer Staples | 12.37% |
| 4 | Technology | 11.26% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
JPMorgan Chase
JPM
$824B
| $12.3M | 5.19% |
142,552
-552
| -0.4% | -$47.6K |
|
2
Wells Fargo
WFC
$262B
| $12.2M | 5.16% |
221,885
-971
| -0.4% | -$53.5K |
|
3
UnitedHealth
UNH
$280B
| $11.9M | 5.01% |
74,142
-355
| -0.5% | -$56.8K |
|
|
4
Comcast
CMCSA
$126B
| $11M | 4.65% |
159,581
+41,576
| +35% | +$2.87M |
|
5
Mastercard
MA
$535B
| $10.3M | 4.36% |
100,127
-432
| -0.4% | -$44.6K |
|
6
Apple
AAPL
$3.41T
| $10.3M | 4.35% |
88,984
-416
| -0.5% | -$48.2K |
|
7
Johnson & Johnson
JNJ
$429B
| $10M | 4.23% |
87,078
-457
| -0.5% | -$52.7K |
|
8
TJX Companies
TJX
$155B
| $9.94M | 4.19% |
132,267
-545
| -0.4% | -$40.9K |
|
9
RTX Corp
RTX
$212B
| $9.72M | 4.1% |
88,706
-377
| -0.4% | -$41.3K |
|
10
Blackrock
BLK
$173B
| $9.7M | 4.09% |
25,490
-121
| -0.5% | -$46K |
|
11
Accenture
ACN
$160B
| $9.29M | 3.92% |
79,341
-349
| -0.4% | -$40.9K |
|
12
CVS Health
CVS
$94B
| $8.87M | 3.74% |
112,378
-506
| -0.4% | -$39.9K |
|
13
Walt Disney
DIS
$213B
| $8.53M | 3.6% |
81,830
-315
| -0.4% | -$32.8K |
|
14
Procter & Gamble
PG
$370B
| $7.8M | 3.29% |
92,747
-461
| -0.5% | -$38.8K |
|
|
15
Medtronic
MDT
$120B
| $7.7M | 3.25% |
108,146
-1,283
| -1% | -$91.4K |
|
16
PepsiCo
PEP
$206B
| $7.57M | 3.2% |
72,389
-314
| -0.4% | -$32.9K |
|
17
Schlumberger
SLB
$53.6B
| $6.97M | 2.94% |
83,008
-314
| -0.4% | -$26.4K |
|
|
DD
18
DELISTED
Du Pont De Nemours E I
DD
| $6.65M | 2.8% |
90,538
-319
| -0.4% | -$23.4K |
|
19
Exxon Mobil
XOM
$489B
| $6.6M | 2.78% |
73,080
-295
| -0.4% | -$26.6K |
|
20
Becton Dickinson
BDX
$53.9B
| $6.07M | 2.56% |
36,679
-126
| -0.3% | -$20.9K |
|
21
Oracle
ORCL
$633B
| $6.04M | 2.55% |
157,047
-651
| -0.4% | -$25K |
|
22
W.W. Grainger
GWW
$48.6B
| $6M | 2.53% |
25,835
-69
| -0.3% | -$16K |
|
|
23
AB InBev
BUD
$120B
| $5.4M | 2.28% |
51,235
-867
| -2% | -$91.4K |
|
|
24
Gilead Sciences
GILD
$140B
| $5.24M | 2.21% |
73,142
-1,870
| -2% | -$134K |
|
25
Coca-Cola
KO
$297B
| $4.83M | 2.04% |
116,409
-411
| -0.4% | -$17K |
|